Isebaert S, Van Audenhove C, Haustermans K, Junius S, Joniau S, De Ridder K, Van Poppel H
Department of Radiation Oncology, University Hospitals Gasthuisberg, Belgium.
Urol Int. 2008;81(4):383-8. doi: 10.1159/000167833. Epub 2008 Dec 10.
The aim of the study was to evaluate the usefulness of a decision aid regarding treatment options for patients with early-stage localized prostate cancer.
50 patients with newly diagnosed localized prostate cancer received the decision aid and were interviewed twice: before the decision-making consultation with the physicians and before treatment or, in case of watchful waiting, before the follow-up consultation. The physicians (radiation oncologists and urologists) were interviewed after the consultation.
The patients became more active partners in the decision-making process: They were better prepared for the consultation, asked more direct information, and were able to make a more deliberative choice. Generally, the use of the decision aid improved the quality of the consultation and resulted in a treatment decision agreed upon by both parties. Sometimes the consultation turned out to be more time-consuming. The decision aid did not only improve the patient-physician interaction but also helped patients to discuss the disease with their partner and family members.
The use of the decision aid has a positive impact on the consultation and the decision-making process. The policy of involving patients more actively in the decision process should be further implemented in daily practice.
本研究旨在评估一种决策辅助工具对早期局限性前列腺癌患者治疗方案选择的有用性。
50例新诊断为局限性前列腺癌的患者接受了决策辅助工具，并接受了两次访谈：一次是在与医生进行决策咨询之前，另一次是在治疗前，或者在进行观察等待的情况下，是在随访咨询之前。医生（放射肿瘤学家和泌尿科医生）在咨询后接受了访谈。
患者在决策过程中成为更积极的参与者：他们为咨询做了更好的准备，询问了更直接的信息，并且能够做出更慎重的选择。总体而言，使用决策辅助工具提高了咨询质量，并达成了双方都同意的治疗决定。有时咨询会变得更耗时。决策辅助工具不仅改善了医患互动，还帮助患者与伴侣和家庭成员讨论病情。
使用决策辅助工具对咨询和决策过程有积极影响。应在日常实践中进一步实施让患者更积极参与决策过程的政策。
